BIVI
Price
$1.76
Change
+$0.17 (+10.69%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
13.11M
SCNI
Price
$1.54
Change
-$0.02 (-1.28%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
1.5M
Interact to see
Advertisement

BIVI vs SCNI

Header iconBIVI vs SCNI Comparison
Open Charts BIVI vs SCNIBanner chart's image
BioVie
Price$1.76
Change+$0.17 (+10.69%)
Volume$16.07K
Capitalization13.11M
Scinai Immunotherapeutics
Price$1.54
Change-$0.02 (-1.28%)
Volume$3K
Capitalization1.5M
BIVI vs SCNI Comparison Chart in %
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIVI vs. SCNI commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Buy and SCNI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BIVI: $1.59 vs. SCNI: $1.56)
Brand notoriety: BIVI and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 74% vs. SCNI: 4%
Market capitalization -- BIVI: $13.11M vs. SCNI: $1.5M
BIVI [@Biotechnology] is valued at $13.11M. SCNI’s [@Biotechnology] market capitalization is $1.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileSCNI’s FA Score has 2 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • SCNI’s FA Score: 2 green, 3 red.
According to our system of comparison, SCNI is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 6 TA indicator(s) are bullish while SCNI’s TA Score has 5 bullish TA indicator(s).

  • BIVI’s TA Score: 6 bullish, 2 bearish.
  • SCNI’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, both BIVI and SCNI are a good buy in the short-term.

Price Growth

BIVI (@Biotechnology) experienced а +7.43% price change this week, while SCNI (@Biotechnology) price change was +6.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIVI($13.1M) has a higher market cap than SCNI($1.5M). SCNI YTD gains are higher at: -53.363 vs. BIVI (-92.050). SCNI has higher annual earnings (EBITDA): 7.8M vs. BIVI (-18M). BIVI has more cash in the bank: 8.01M vs. SCNI (1.03M). BIVI has less debt than SCNI: BIVI (366K) vs SCNI (1.23M). SCNI has higher revenues than BIVI: SCNI (452K) vs BIVI (0).
BIVISCNIBIVI / SCNI
Capitalization13.1M1.5M873%
EBITDA-18M7.8M-231%
Gain YTD-92.050-53.363172%
P/E RatioN/A0.38-
Revenue0452K-
Total Cash8.01M1.03M776%
Total Debt366K1.23M30%
FUNDAMENTALS RATINGS
BIVI vs SCNI: Fundamental Ratings
BIVI
SCNI
OUTLOOK RATING
1..100
227
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
997
PRICE GROWTH RATING
1..100
9965
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIVI's Valuation (12) in the null industry is in the same range as SCNI (14) in the Pharmaceuticals Major industry. This means that BIVI’s stock grew similarly to SCNI’s over the last 12 months.

BIVI's Profit vs Risk Rating (100) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that BIVI’s stock grew similarly to SCNI’s over the last 12 months.

SCNI's SMR Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for BIVI (99) in the null industry. This means that SCNI’s stock grew significantly faster than BIVI’s over the last 12 months.

SCNI's Price Growth Rating (65) in the Pharmaceuticals Major industry is somewhat better than the same rating for BIVI (99) in the null industry. This means that SCNI’s stock grew somewhat faster than BIVI’s over the last 12 months.

SCNI's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as BIVI (100) in the null industry. This means that SCNI’s stock grew similarly to BIVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIVISCNI
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ERAS1.480.05
+3.50%
Erasca
MCHPP59.831.10
+1.87%
Microchip Technology Inc
ORI41.090.73
+1.81%
Old Republic International Corp
WBTN14.56-0.09
-0.61%
Webtoon Entertainment Inc.
AACG2.15-0.05
-2.27%
ATA Creativity Global

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HURA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
-4.79%
HURA - BIVI
45%
Loosely correlated
-2.69%
HOFBF - BIVI
44%
Loosely correlated
N/A
SCNI - BIVI
34%
Loosely correlated
-3.11%
LGVN - BIVI
32%
Poorly correlated
-8.31%
NEVPF - BIVI
27%
Poorly correlated
N/A
More

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with TAOX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-3.11%
TAOX - SCNI
73%
Closely correlated
-3.50%
SYRE - SCNI
43%
Loosely correlated
+1.07%
MBIO - SCNI
37%
Loosely correlated
-4.55%
BIVI - SCNI
34%
Loosely correlated
-4.79%
VANI - SCNI
32%
Poorly correlated
+18.10%
More